CNTO-530

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameCNTO-530
Drug Alias NameCNTO-530
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCentocor
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCentocor
Active IndicationsN/A
Inactive IndicationsAnemia

Other Information

ATC CodeN/A
Related LinksN/A